Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital

•In this study, we re-staged patients with stage III small cell lung cancer (SCLC) from both SEER database and our hospital according to 8th TNM classification.•Propensity score matching (PSM) was used to balance clinical bias.•Surgery improved survival in patients with stage III SCLC, when compared...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2021-12, Vol.162, p.54-60
Hauptverfasser: Gao, Lin, Shen, Lan, Wang, Kaixuan, Lu, Shun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 60
container_issue
container_start_page 54
container_title Lung cancer (Amsterdam, Netherlands)
container_volume 162
creator Gao, Lin
Shen, Lan
Wang, Kaixuan
Lu, Shun
description •In this study, we re-staged patients with stage III small cell lung cancer (SCLC) from both SEER database and our hospital according to 8th TNM classification.•Propensity score matching (PSM) was used to balance clinical bias.•Surgery improved survival in patients with stage III SCLC, when compared with non-surgical treatment.•Lobectomy (LB) is the optimal surgery type for stage III SCLC patients. Patients with very early stage small cell lung cancer (SCLC) can benefit from surgery. However, the role of surgery in local advanced SCLC patients remains controversial. We designed this study to investigate the role of surgery on survival of this subset population. The included patients were identified from the Surveillance, Epidemiology, and End Results SEER database from 1998 to 2016 and Shanghai Chest Hospital of China from 2009 to 2016. Propensity score matching(PSM) was used to balance clinical bias. The overall survival (OS) and lung cancer-specific survival (LCSS) were compared by the Kaplan–Meier analysis. Cox proportional hazards regression was used to identify factors associated with survival. Among the 3005 stage Ⅲ patients, 570 (18.97%) patients underwent surgery. Compared with non-surgical group, patients undergoing surgery were more likely to be male, had smaller tumor size, mediastinal lymph node involvement and lower pathologic stage. The Kaplan-Meier analysis showed that surgical patients had a better OS and LCSS before and after PSM. 418 surgical patients were well matched with non-surgical patients. In matched surgical group, there were 224 (53.59%) patients who underwent lobectomy (LB), 147 (35.17%) patients who received sublobectomy (SLB), 31 (7.41%) patients who underwent pneumonectomy and 16 (3.83%) patients with unknown surgery type. The 5-year OS of the 4 subgroups were 28.80%, 12.50%, 8.70% and 13.50%, respectively (P = 0.002). In a multivariable Cox model, SLB (hazard ratio, 1.53; 95%CI, 1.20–1.96; P = 0.001) and pneumonectomy (hazard ratio, 1.72; 95%CI, 1.12–2.65; P = 0.013) were associated with worse OS compared with LB. Surgical resection significantly improved OS and LCSS of stage Ⅲ SCLC patients in our study. Furthermore, LB had advantage over other surgery type but further exploration in larger prospective clinical trials is needed.
doi_str_mv 10.1016/j.lungcan.2021.10.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2594297046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169500221005808</els_id><sourcerecordid>2594297046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-9275f29d88c117edc8cd93f16f56ab44743e33266f417ce0c9a16c93f967e323</originalsourceid><addsrcrecordid>eNqFUUuO1DAQjRCIaQaOAKolmzS28zUbhFoNM9LwEdOsLbdd6biVxMF2RsoBuAiH4gCcBGe6hy0bW_X86tVzvSR5ScmaElq-Oa67aTgoOawZYTRia0L4o2RF64qldZaxx8kq8nhaEMIukmfeHwmhFSX8aXKR5VXG6yJfJb-_Ojvi4E2YwSvrEHoZVIsa5CC72RsPjXUQWgRnOwTbgJ_cAd0MZgAf5AHhz89f4HvZdaAwHosviMYUOthLH6XscC-A5tCGFlCbYCIUpRZ09_kTqE56bxqj5PLyFiSMdpy6-yoOmfT8wP5-C7fb7TfQMshFPNqMVmHTmgFj1Vo_miC758mTRnYeX5zvy2T3YbvbXKU3Xz5eb97fpCori5ByVhUN47quFaUValUrzbOGlk1Ryn2eV3mGcZVl2eS0UkgUl7RUkcHLCjOWXSavT7Kjsz8m9EH0xi9LkAPayQtW8JzxiuRlpBYnqnLWe4eNGJ3ppZsFJWJJVBzFOVGxJLrAMdHY9-o8Ytr3qP91PUQYCe9OBIz_vDPohFcG4_a1caiC0Nb8Z8RfM164qw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2594297046</pqid></control><display><type>article</type><title>Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gao, Lin ; Shen, Lan ; Wang, Kaixuan ; Lu, Shun</creator><creatorcontrib>Gao, Lin ; Shen, Lan ; Wang, Kaixuan ; Lu, Shun</creatorcontrib><description>•In this study, we re-staged patients with stage III small cell lung cancer (SCLC) from both SEER database and our hospital according to 8th TNM classification.•Propensity score matching (PSM) was used to balance clinical bias.•Surgery improved survival in patients with stage III SCLC, when compared with non-surgical treatment.•Lobectomy (LB) is the optimal surgery type for stage III SCLC patients. Patients with very early stage small cell lung cancer (SCLC) can benefit from surgery. However, the role of surgery in local advanced SCLC patients remains controversial. We designed this study to investigate the role of surgery on survival of this subset population. The included patients were identified from the Surveillance, Epidemiology, and End Results SEER database from 1998 to 2016 and Shanghai Chest Hospital of China from 2009 to 2016. Propensity score matching(PSM) was used to balance clinical bias. The overall survival (OS) and lung cancer-specific survival (LCSS) were compared by the Kaplan–Meier analysis. Cox proportional hazards regression was used to identify factors associated with survival. Among the 3005 stage Ⅲ patients, 570 (18.97%) patients underwent surgery. Compared with non-surgical group, patients undergoing surgery were more likely to be male, had smaller tumor size, mediastinal lymph node involvement and lower pathologic stage. The Kaplan-Meier analysis showed that surgical patients had a better OS and LCSS before and after PSM. 418 surgical patients were well matched with non-surgical patients. In matched surgical group, there were 224 (53.59%) patients who underwent lobectomy (LB), 147 (35.17%) patients who received sublobectomy (SLB), 31 (7.41%) patients who underwent pneumonectomy and 16 (3.83%) patients with unknown surgery type. The 5-year OS of the 4 subgroups were 28.80%, 12.50%, 8.70% and 13.50%, respectively (P = 0.002). In a multivariable Cox model, SLB (hazard ratio, 1.53; 95%CI, 1.20–1.96; P = 0.001) and pneumonectomy (hazard ratio, 1.72; 95%CI, 1.12–2.65; P = 0.013) were associated with worse OS compared with LB. Surgical resection significantly improved OS and LCSS of stage Ⅲ SCLC patients in our study. Furthermore, LB had advantage over other surgery type but further exploration in larger prospective clinical trials is needed.</description><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/j.lungcan.2021.10.009</identifier><identifier>PMID: 34739854</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>China - epidemiology ; Female ; Hospitals ; Humans ; Lobectomy ; Lung Neoplasms - epidemiology ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Male ; Neoplasm Staging ; Pneumonectomy ; Propensity Score ; Prospective Studies ; SEER ; SEER Program ; Small cell lung cancer ; Small Cell Lung Carcinoma - epidemiology ; Small Cell Lung Carcinoma - pathology ; Small Cell Lung Carcinoma - surgery ; Stage ; Surgery</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.54-60</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-9275f29d88c117edc8cd93f16f56ab44743e33266f417ce0c9a16c93f967e323</citedby><cites>FETCH-LOGICAL-c365t-9275f29d88c117edc8cd93f16f56ab44743e33266f417ce0c9a16c93f967e323</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0169500221005808$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34739854$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gao, Lin</creatorcontrib><creatorcontrib>Shen, Lan</creatorcontrib><creatorcontrib>Wang, Kaixuan</creatorcontrib><creatorcontrib>Lu, Shun</creatorcontrib><title>Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><description>•In this study, we re-staged patients with stage III small cell lung cancer (SCLC) from both SEER database and our hospital according to 8th TNM classification.•Propensity score matching (PSM) was used to balance clinical bias.•Surgery improved survival in patients with stage III SCLC, when compared with non-surgical treatment.•Lobectomy (LB) is the optimal surgery type for stage III SCLC patients. Patients with very early stage small cell lung cancer (SCLC) can benefit from surgery. However, the role of surgery in local advanced SCLC patients remains controversial. We designed this study to investigate the role of surgery on survival of this subset population. The included patients were identified from the Surveillance, Epidemiology, and End Results SEER database from 1998 to 2016 and Shanghai Chest Hospital of China from 2009 to 2016. Propensity score matching(PSM) was used to balance clinical bias. The overall survival (OS) and lung cancer-specific survival (LCSS) were compared by the Kaplan–Meier analysis. Cox proportional hazards regression was used to identify factors associated with survival. Among the 3005 stage Ⅲ patients, 570 (18.97%) patients underwent surgery. Compared with non-surgical group, patients undergoing surgery were more likely to be male, had smaller tumor size, mediastinal lymph node involvement and lower pathologic stage. The Kaplan-Meier analysis showed that surgical patients had a better OS and LCSS before and after PSM. 418 surgical patients were well matched with non-surgical patients. In matched surgical group, there were 224 (53.59%) patients who underwent lobectomy (LB), 147 (35.17%) patients who received sublobectomy (SLB), 31 (7.41%) patients who underwent pneumonectomy and 16 (3.83%) patients with unknown surgery type. The 5-year OS of the 4 subgroups were 28.80%, 12.50%, 8.70% and 13.50%, respectively (P = 0.002). In a multivariable Cox model, SLB (hazard ratio, 1.53; 95%CI, 1.20–1.96; P = 0.001) and pneumonectomy (hazard ratio, 1.72; 95%CI, 1.12–2.65; P = 0.013) were associated with worse OS compared with LB. Surgical resection significantly improved OS and LCSS of stage Ⅲ SCLC patients in our study. Furthermore, LB had advantage over other surgery type but further exploration in larger prospective clinical trials is needed.</description><subject>China - epidemiology</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Lobectomy</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Male</subject><subject>Neoplasm Staging</subject><subject>Pneumonectomy</subject><subject>Propensity Score</subject><subject>Prospective Studies</subject><subject>SEER</subject><subject>SEER Program</subject><subject>Small cell lung cancer</subject><subject>Small Cell Lung Carcinoma - epidemiology</subject><subject>Small Cell Lung Carcinoma - pathology</subject><subject>Small Cell Lung Carcinoma - surgery</subject><subject>Stage</subject><subject>Surgery</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUUuO1DAQjRCIaQaOAKolmzS28zUbhFoNM9LwEdOsLbdd6biVxMF2RsoBuAiH4gCcBGe6hy0bW_X86tVzvSR5ScmaElq-Oa67aTgoOawZYTRia0L4o2RF64qldZaxx8kq8nhaEMIukmfeHwmhFSX8aXKR5VXG6yJfJb-_Ojvi4E2YwSvrEHoZVIsa5CC72RsPjXUQWgRnOwTbgJ_cAd0MZgAf5AHhz89f4HvZdaAwHosviMYUOthLH6XscC-A5tCGFlCbYCIUpRZ09_kTqE56bxqj5PLyFiSMdpy6-yoOmfT8wP5-C7fb7TfQMshFPNqMVmHTmgFj1Vo_miC758mTRnYeX5zvy2T3YbvbXKU3Xz5eb97fpCori5ByVhUN47quFaUValUrzbOGlk1Ryn2eV3mGcZVl2eS0UkgUl7RUkcHLCjOWXSavT7Kjsz8m9EH0xi9LkAPayQtW8JzxiuRlpBYnqnLWe4eNGJ3ppZsFJWJJVBzFOVGxJLrAMdHY9-o8Ytr3qP91PUQYCe9OBIz_vDPohFcG4_a1caiC0Nb8Z8RfM164qw</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Gao, Lin</creator><creator>Shen, Lan</creator><creator>Wang, Kaixuan</creator><creator>Lu, Shun</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202112</creationdate><title>Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital</title><author>Gao, Lin ; Shen, Lan ; Wang, Kaixuan ; Lu, Shun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-9275f29d88c117edc8cd93f16f56ab44743e33266f417ce0c9a16c93f967e323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>China - epidemiology</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Lobectomy</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Male</topic><topic>Neoplasm Staging</topic><topic>Pneumonectomy</topic><topic>Propensity Score</topic><topic>Prospective Studies</topic><topic>SEER</topic><topic>SEER Program</topic><topic>Small cell lung cancer</topic><topic>Small Cell Lung Carcinoma - epidemiology</topic><topic>Small Cell Lung Carcinoma - pathology</topic><topic>Small Cell Lung Carcinoma - surgery</topic><topic>Stage</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Lin</creatorcontrib><creatorcontrib>Shen, Lan</creatorcontrib><creatorcontrib>Wang, Kaixuan</creatorcontrib><creatorcontrib>Lu, Shun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Lin</au><au>Shen, Lan</au><au>Wang, Kaixuan</au><au>Lu, Shun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>2021-12</date><risdate>2021</risdate><volume>162</volume><spage>54</spage><epage>60</epage><pages>54-60</pages><issn>0169-5002</issn><eissn>1872-8332</eissn><abstract>•In this study, we re-staged patients with stage III small cell lung cancer (SCLC) from both SEER database and our hospital according to 8th TNM classification.•Propensity score matching (PSM) was used to balance clinical bias.•Surgery improved survival in patients with stage III SCLC, when compared with non-surgical treatment.•Lobectomy (LB) is the optimal surgery type for stage III SCLC patients. Patients with very early stage small cell lung cancer (SCLC) can benefit from surgery. However, the role of surgery in local advanced SCLC patients remains controversial. We designed this study to investigate the role of surgery on survival of this subset population. The included patients were identified from the Surveillance, Epidemiology, and End Results SEER database from 1998 to 2016 and Shanghai Chest Hospital of China from 2009 to 2016. Propensity score matching(PSM) was used to balance clinical bias. The overall survival (OS) and lung cancer-specific survival (LCSS) were compared by the Kaplan–Meier analysis. Cox proportional hazards regression was used to identify factors associated with survival. Among the 3005 stage Ⅲ patients, 570 (18.97%) patients underwent surgery. Compared with non-surgical group, patients undergoing surgery were more likely to be male, had smaller tumor size, mediastinal lymph node involvement and lower pathologic stage. The Kaplan-Meier analysis showed that surgical patients had a better OS and LCSS before and after PSM. 418 surgical patients were well matched with non-surgical patients. In matched surgical group, there were 224 (53.59%) patients who underwent lobectomy (LB), 147 (35.17%) patients who received sublobectomy (SLB), 31 (7.41%) patients who underwent pneumonectomy and 16 (3.83%) patients with unknown surgery type. The 5-year OS of the 4 subgroups were 28.80%, 12.50%, 8.70% and 13.50%, respectively (P = 0.002). In a multivariable Cox model, SLB (hazard ratio, 1.53; 95%CI, 1.20–1.96; P = 0.001) and pneumonectomy (hazard ratio, 1.72; 95%CI, 1.12–2.65; P = 0.013) were associated with worse OS compared with LB. Surgical resection significantly improved OS and LCSS of stage Ⅲ SCLC patients in our study. Furthermore, LB had advantage over other surgery type but further exploration in larger prospective clinical trials is needed.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>34739854</pmid><doi>10.1016/j.lungcan.2021.10.009</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-5002
ispartof Lung cancer (Amsterdam, Netherlands), 2021-12, Vol.162, p.54-60
issn 0169-5002
1872-8332
language eng
recordid cdi_proquest_miscellaneous_2594297046
source MEDLINE; Elsevier ScienceDirect Journals
subjects China - epidemiology
Female
Hospitals
Humans
Lobectomy
Lung Neoplasms - epidemiology
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Male
Neoplasm Staging
Pneumonectomy
Propensity Score
Prospective Studies
SEER
SEER Program
Small cell lung cancer
Small Cell Lung Carcinoma - epidemiology
Small Cell Lung Carcinoma - pathology
Small Cell Lung Carcinoma - surgery
Stage
Surgery
title Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A54%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Propensity%20score%20matched%20analysis%20for%20the%20role%20of%20surgery%20in%20stage%20%E2%85%A2%20small%20cell%20lung%20cancer%20based%20on%20the%20eighth%20edition%20of%20the%20TNM%20classification:%20a%20population%20study%20of%20the%20US%20SEER%20database%20and%20a%20Chinese%20hospital&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Gao,%20Lin&rft.date=2021-12&rft.volume=162&rft.spage=54&rft.epage=60&rft.pages=54-60&rft.issn=0169-5002&rft.eissn=1872-8332&rft_id=info:doi/10.1016/j.lungcan.2021.10.009&rft_dat=%3Cproquest_cross%3E2594297046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2594297046&rft_id=info:pmid/34739854&rft_els_id=S0169500221005808&rfr_iscdi=true